DSM-5 and clinical trials in psychiatry: challenges to come?

Florence Butlen-Ducuing, Manuel Haas,Luca Pani, Barbara van Zwieten-Boot,Karl Broich

NATURE REVIEWS DRUG DISCOVERY（2012）

引用 8|浏览1

暂无评分

摘要

The publication of the fifth version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) in 2013 raises important questions for clinical trials and associated regulatory decisions on new drugs for psychiatric disorders.

查看译文

关键词

Clinical trials,Drug regulation,Health policy,Psychiatric disorders,Biomedicine,general,Pharmacology/Toxicology,Biotechnology,Medicinal Chemistry,Molecular Medicine,Cancer Research

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要